What is Algorithmic Biologics?
Founded in 2020, Algorithmic Biologics operates at the intersection of molecular science and technology. The company is dedicated to advancing molecular technology development, positioning itself as a key player in India's burgeoning deep-tech sector. Its focus on innovation in this specialized field suggests a commitment to addressing complex biological challenges through advanced computational and scientific approaches.
How much funding has Algorithmic Biologics raised?
Algorithmic Biologics has raised a total of $2.5M across 1 funding round:
Series A
$2.5M
Series A (2024): $2.5M with participation from Axilor Ventures and Bharat Innovation Fund
Key Investors in Algorithmic Biologics
Axilor Ventures
Axilor Ventures is a platform dedicated to supporting early-stage startups through accelerator and seed fund programs. It was founded by prominent entrepreneurs and business leaders, aiming to enhance startup success rates and foster an active founder network.
Bharat Innovation Fund
Bharat Innovation Fund is a venture capital and private equity firm established in 2017, focusing on early-stage, deep-tech, and intellectual property ventures. Based in Bengaluru, India, it actively invests in innovative technology companies.
What's next for Algorithmic Biologics?
The recent major strategic investment in Algorithmic Biologics signals a pivotal growth phase for the company. This capital infusion is expected to fuel further research and development, potentially enabling the scaling of its molecular technology platforms and expanding its market reach. The backing from venture capital firms specializing in early-stage and deep-tech ventures indicates strong confidence in the company's long-term potential and its ability to innovate within the molecular technology domain.
See full Algorithmic Biologics company page
